- Wealth PMS (50L+)
On the 29-Jan-16 (Tuesday), the US FDA issued a Warning Letter to IPCA Laboratories.
The letter was in relation to the:Inspection performed during July, 2014 at Ratlam (Madhya Pradesh) observations in Form FDA 483 which subsequently resulted into issuance of import alert on the said manufacturing unit by the US FDA on 22-Jan-15 Inspection of the formulations manufacturing units situated at SEZ Indore (Pithampur) and Piparia (Silvassa) which resulted in Form . . .